Protein Biomarkers in Risk and Prognosis of Amyotrophic Lateral Sclerosis
Plasma and cerebrospinal fluid (CSF) protein biomarkers in amyotrophic lateral sclerosis (ALS) may provide insight into disease mechanisms and yield clinically useful biomarkers.